Search research articles
Contact Us
Filters
Showing results (21-30 of 42) with videos related to
Page
of 5
Sort By:
BMC Psychiatry
|
November 2, 2015
Treatment of early non-response in patients with schizophrenia: assessing the efficacy of antipsychotic dose escalation
Antony Loebel, Leslie Citrome, Christoph U Correll, et al.
Journal of Psychiatric Research
|
February 21, 2013
Lurasidone for the treatment of acutely psychotic patients with schizophrenia: a 6-week, randomized, placebo-controlled study
Henry A Nasrallah, Robert Silva, Debra Phillips, et al.
The Journal of Trauma and Acute Care Surgery
|
February 22, 2023
National trends and clinical outcomes of interventional approaches following admission for infected necrotizing pancreatitis in the United States
Zachary Tran, Jane Xu, Arjun Verma, et al.
The American Journal of Psychiatry
|
October 31, 2013
Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study
Antony Loebel, Josephine Cucchiaro, Robert Silva, et al.
BMC Psychiatry
|
May 7, 2020
Switching to Lurasidone following 12 months of treatment with Risperidone: results of a 6-month, open-label study
Greg W Mattingly, Peter M Haddad, Michael Tocco, et al.
Molecular and Biochemical Parasitology
|
August 8, 2002
The kinetics of uptake and accumulation of 3,6-bis-omega-diethylamino-amyloxyxanthone by the human malaria parasite Plasmodium falciparum
Jane Xu Kelly, R W Winter, Anda Cornea, et al.
Journal of Medicinal Chemistry
|
September 1, 2006
A chloroquine-like molecule designed to reverse resistance in Plasmodium falciparum
Steven J Burgess, Audrey Selzer, Jane Xu Kelly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 31, 2015
Enhanced Antitumor Activity of an Anti-5T4 Antibody-Drug Conjugate in Combination with PI3K/mTOR inhibitors or Taxanes
Boris Shor, Jennifer Kahler, Maureen Dougher, et al.
Precision Clinical Medicine
|
April 3, 2023
Dysregulated miRNAs modulate tumor microenvironment associated signaling networks in pancreatic ductal adenocarcinoma
Tiantian Liu, Zhong Chen, Wanqiu Chen, et al.
Molecular and Biochemical Parasitology
|
January 30, 2003
Antileishmanial drug development: exploitation of parasite heme dependency
Jane Xu Kelly, Marina V Ignatushchenko, H G Bouwer, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 42) with videos related to
Sort By:
Page
of 5
BMC Psychiatry
|
November 2, 2015
Treatment of early non-response in patients with schizophrenia: assessing the efficacy of antipsychotic dose escalation
Antony Loebel, Leslie Citrome, Christoph U Correll, et al.
Journal of Psychiatric Research
|
February 21, 2013
Lurasidone for the treatment of acutely psychotic patients with schizophrenia: a 6-week, randomized, placebo-controlled study
Henry A Nasrallah, Robert Silva, Debra Phillips, et al.
The Journal of Trauma and Acute Care Surgery
|
February 22, 2023
National trends and clinical outcomes of interventional approaches following admission for infected necrotizing pancreatitis in the United States
Zachary Tran, Jane Xu, Arjun Verma, et al.
The American Journal of Psychiatry
|
October 31, 2013
Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study
Antony Loebel, Josephine Cucchiaro, Robert Silva, et al.
BMC Psychiatry
|
May 7, 2020
Switching to Lurasidone following 12 months of treatment with Risperidone: results of a 6-month, open-label study
Greg W Mattingly, Peter M Haddad, Michael Tocco, et al.
Molecular and Biochemical Parasitology
|
August 8, 2002
The kinetics of uptake and accumulation of 3,6-bis-omega-diethylamino-amyloxyxanthone by the human malaria parasite Plasmodium falciparum
Jane Xu Kelly, R W Winter, Anda Cornea, et al.
Journal of Medicinal Chemistry
|
September 1, 2006
A chloroquine-like molecule designed to reverse resistance in Plasmodium falciparum
Steven J Burgess, Audrey Selzer, Jane Xu Kelly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 31, 2015
Enhanced Antitumor Activity of an Anti-5T4 Antibody-Drug Conjugate in Combination with PI3K/mTOR inhibitors or Taxanes
Boris Shor, Jennifer Kahler, Maureen Dougher, et al.
Precision Clinical Medicine
|
April 3, 2023
Dysregulated miRNAs modulate tumor microenvironment associated signaling networks in pancreatic ductal adenocarcinoma
Tiantian Liu, Zhong Chen, Wanqiu Chen, et al.
Molecular and Biochemical Parasitology
|
January 30, 2003
Antileishmanial drug development: exploitation of parasite heme dependency
Jane Xu Kelly, Marina V Ignatushchenko, H G Bouwer, et al.
Page
of 5